Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent cancer and the fifth leading cause of cancer death among men in 2022. Hormone ...

When "Dilbert" creator Scott Adams recently made a public plea for help accessing a life-extending cancer treatment, the story drew national attention — and sparked some questions about the drug ...

Vir Biotechnology has reported positive updated Phase 1 results for VIR-5500, an experimental pill-form therapy targeting metastatic prostate cancer that researchers have called “stunning.” The drug, ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a campaign by a patient and a charity. Abiraterone has been provided on the NHS ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after NHS chiefs widened access to the treatment. Around 2,000 men diagnosed ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology for the treatment of early-stage ...

A major study of nearly 19,000 men has found that a baldness drug significantly cut the risk of prostate cancer, but its side effects may keep many from using it to prevent what has become the second ...

Taking one-fourth the standard dose of a widely used drug for prostate cancer with a low-fat breakfast can be as effective - and four times less expensive - as taking the standard dose as recommended: ...